Maureen Sijtsema , Thijs Stringer , Nonke E.M. Hopman , Linda van der Graaf – van Bloois , Birgitta Duim , Astrid van den Brom-Spierenburg , Mathijs Theelen , Aldert Zomer , Els M. Broens
{"title":"Active surveillance in an equine intensive care unit identifies clusters of ESKAPEE pathogens in the veterinary hospital environment","authors":"Maureen Sijtsema , Thijs Stringer , Nonke E.M. Hopman , Linda van der Graaf – van Bloois , Birgitta Duim , Astrid van den Brom-Spierenburg , Mathijs Theelen , Aldert Zomer , Els M. Broens","doi":"10.1016/j.vetmic.2025.110439","DOIUrl":null,"url":null,"abstract":"<div><div>Healthcare-associated infections (HAIs) associated with ESKAPEE pathogens are an emerging concern in equine hospitals, especially in the intensive care unit (ICU). To gain insight into the occurrence of HAIs and to identify potential reservoirs and transmission routes of ESKAPEE pathogens in an equine ICU, a pilot study of two periods (December 2022-January 2023 and April-June 2023) was performed, where patient and environmental samples were obtained upon ICU admission and discharge. A sampling and laboratory protocol for the detection and identification of different ESKAPEE pathogens and <em>Salmonella</em> spp. was developed. Samples consisted of patient samples and patient-bound environmental samples, including nose and environmental swabs, feces, twitch ropes and catheter tips. Non-patient bound samples were collected from high-contact surfaces for staff members. In total, 271 patient-bound samples (n = 122 in sampling period 1 and n = 149 in sampling period 2) from 30 patients and 28 non-patient bound environmental samples were collected resulting in the isolation of 207 ESKAPEE isolates. A selection of isolates (n = 115) was sequenced to identify clusters and antimicrobial resistance genes. ESKAPEE pathogens were present in 90 % of the horses hospitalized at the ICU or their immediate environment. Different genetic clusters of MRSA, <em>A. baumannii</em> and <em>E. cloacae</em> isolates were identified over time suggesting transmission and persistence within the ICU. During both sampling periods no HAIs were observed, but the abundance of these pathogens might pose a risk for HAIs. This study shows the importance for every (veterinary) hospital to implement surveillance and to further optimize hygiene protocols.</div></div>","PeriodicalId":23551,"journal":{"name":"Veterinary microbiology","volume":"303 ","pages":"Article 110439"},"PeriodicalIF":2.7000,"publicationDate":"2025-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Veterinary microbiology","FirstCategoryId":"97","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0378113525000744","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Healthcare-associated infections (HAIs) associated with ESKAPEE pathogens are an emerging concern in equine hospitals, especially in the intensive care unit (ICU). To gain insight into the occurrence of HAIs and to identify potential reservoirs and transmission routes of ESKAPEE pathogens in an equine ICU, a pilot study of two periods (December 2022-January 2023 and April-June 2023) was performed, where patient and environmental samples were obtained upon ICU admission and discharge. A sampling and laboratory protocol for the detection and identification of different ESKAPEE pathogens and Salmonella spp. was developed. Samples consisted of patient samples and patient-bound environmental samples, including nose and environmental swabs, feces, twitch ropes and catheter tips. Non-patient bound samples were collected from high-contact surfaces for staff members. In total, 271 patient-bound samples (n = 122 in sampling period 1 and n = 149 in sampling period 2) from 30 patients and 28 non-patient bound environmental samples were collected resulting in the isolation of 207 ESKAPEE isolates. A selection of isolates (n = 115) was sequenced to identify clusters and antimicrobial resistance genes. ESKAPEE pathogens were present in 90 % of the horses hospitalized at the ICU or their immediate environment. Different genetic clusters of MRSA, A. baumannii and E. cloacae isolates were identified over time suggesting transmission and persistence within the ICU. During both sampling periods no HAIs were observed, but the abundance of these pathogens might pose a risk for HAIs. This study shows the importance for every (veterinary) hospital to implement surveillance and to further optimize hygiene protocols.
与ESKAPEE病原体相关的医疗保健相关感染(HAIs)在马医院,特别是在重症监护病房(ICU)中是一个新出现的问题。为了深入了解HAIs的发生情况,并确定ESKAPEE病原体在马ICU中的潜在宿主和传播途径,进行了一项为期两个时期(2022年12月至2023年1月和2023年4月至6月)的试点研究,在ICU入院和出院时获取患者和环境样本。为检测和鉴定不同的ESKAPEE病原体和沙门氏菌制定了采样和实验室方案。样本包括患者样本和患者环境样本,包括鼻拭子和环境拭子、粪便、抽搐绳和导管尖端。从工作人员的高接触表面收集非患者束缚样本。共从30例患者和28例非患者环境样本中收集了271例患者结合样本(采样期1 n = 122例,采样期2 n = 149例),分离出207株ESKAPEE分离株。选取分离株(n = 115)进行测序,鉴定菌群和耐药基因。90% %在ICU住院的马或其直接环境中存在ESKAPEE病原体。随着时间的推移,发现了MRSA、鲍曼不动杆菌和阴沟不动杆菌的不同遗传群,表明在ICU内传播和持续存在。在两次采样期间均未观察到HAIs,但这些病原体的丰富可能构成HAIs的风险。本研究显示了每个(兽医)医院实施监测和进一步优化卫生规程的重要性。
期刊介绍:
Veterinary Microbiology is concerned with microbial (bacterial, fungal, viral) diseases of domesticated vertebrate animals (livestock, companion animals, fur-bearing animals, game, poultry, fish) that supply food, other useful products or companionship. In addition, Microbial diseases of wild animals living in captivity, or as members of the feral fauna will also be considered if the infections are of interest because of their interrelation with humans (zoonoses) and/or domestic animals. Studies of antimicrobial resistance are also included, provided that the results represent a substantial advance in knowledge. Authors are strongly encouraged to read - prior to submission - the Editorials (''Scope or cope'' and ''Scope or cope II'') published previously in the journal. The Editors reserve the right to suggest submission to another journal for those papers which they feel would be more appropriate for consideration by that journal.
Original research papers of high quality and novelty on aspects of control, host response, molecular biology, pathogenesis, prevention, and treatment of microbial diseases of animals are published. Papers dealing primarily with immunology, epidemiology, molecular biology and antiviral or microbial agents will only be considered if they demonstrate a clear impact on a disease. Papers focusing solely on diagnostic techniques (such as another PCR protocol or ELISA) will not be published - focus should be on a microorganism and not on a particular technique. Papers only reporting microbial sequences, transcriptomics data, or proteomics data will not be considered unless the results represent a substantial advance in knowledge.
Drug trial papers will be considered if they have general application or significance. Papers on the identification of microorganisms will also be considered, but detailed taxonomic studies do not fall within the scope of the journal. Case reports will not be published, unless they have general application or contain novel aspects. Papers of geographically limited interest, which repeat what had been established elsewhere will not be considered. The readership of the journal is global.